C5 antigens and uses thereof

Details for Australian Patent Application No. 2008228247 (hide)

Owner Novartis AG

Inventors Milik, Mariusz; Mikhailov, Dmitri; Keating, Mark Taylor; Guild, Braydon Charles; Roguska, Michael; Zhao, Kehao; Splawski, Igor

Agent Davies Collison Cave

Pub. Number AU-A-2008228247

PCT Pub. Number WO2008/113834

Priority 60/896,408 22.03.07 US

Filing date 19 March 2008

Wipo publication date 25 September 2008

International Classifications

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/113834 Priority application(s): WO2008/113834

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228251-Process for the removal of endocrine disrupting compounds

2008228246-Novel human anti-R7V antibodies and uses thereof